Pfizer made changes to the program in 2023 and 2024. Why is Pfizer making changes to the PAP again, in 2025?

Periodically, Pfizer reviews the PAP to confirm it is supporting the evolving needs of patients in a rapidly changing healthcare environment. These changes are a response to the Inflation Reduction Act which caps Medicare Part D/Medicare Advantage patients’ annual out of pocket prescription drug costs for covered medicines at $2,000 and enables patients to have the option to enroll in the Medicare Prescription Payment Plan to spread out their monthly medicine costs.